methyl 2-(phenylsulfinyl)propanoate | 58793-82-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 2-(phenylsulfinyl)propanoate
• 英文别名: 3-Phenylsulfin-propionat；Methyl 2-(benzenesulfinyl)propanoate
• CAS: 58793-82-1
• 化学式: C₁₀H₁₂O₃S
• 分子量: 212.269
• InChiKey: SSWFQSXOYCJKEI-UHFFFAOYSA-N

物化性质

• 沸点：
  351.5±25.0 °C(Predicted)
• 密度：
  1.24±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  62.6
• 氢给体数：
  0
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  methyl 2-(phenylsulfinyl)propanoate 在 甲烷磺酸 、 乙酸酐 作用下， 以 二氯甲烷 为溶剂， 以72%的产率得到methyl 2-(phenylthio)propenoate
  参考文献：
  名称：

  Synthesis and Absolute Configuration of Novel N,O-Psiconucleosides Using (R)-N-Phenylpantolactam as a Resolution Agent

  摘要：

  A series of novel N,O-psiconucleosides has been prepared in both enantiomeric forms by resolution of an advanced racemic synthetic intermediate using (R)-N-phenylpantolactam as a chiral resolution agent. The absolute configuration of all of these compounds has been unequivocally established by chemical correlation with the novel (R)- or (S)-1-methyl-5-phenylpyrrolidine-2.3-dione, prepared from the known (R)- and (S)-1-methyl-5-phenylpyrrolidin-2-one, respectively.

  DOI：

  10.1021/jo800769m
• 作为产物：
  描述：

  methyl 2-(phenylthio)propanoate 在 sodium periodate 作用下， 以 甲醇 、 水 为溶剂， 以92%的产率得到methyl 2-(phenylsulfinyl)propanoate
  参考文献：
  名称：

  Synthesis and Absolute Configuration of Novel N,O-Psiconucleosides Using (R)-N-Phenylpantolactam as a Resolution Agent

  摘要：

  A series of novel N,O-psiconucleosides has been prepared in both enantiomeric forms by resolution of an advanced racemic synthetic intermediate using (R)-N-phenylpantolactam as a chiral resolution agent. The absolute configuration of all of these compounds has been unequivocally established by chemical correlation with the novel (R)- or (S)-1-methyl-5-phenylpyrrolidine-2.3-dione, prepared from the known (R)- and (S)-1-methyl-5-phenylpyrrolidin-2-one, respectively.

  DOI：

  10.1021/jo800769m

文献信息

• Microbial Deracemization of α-Substituted Carboxylic Acids:  Substrate Specificity and Mechanistic Investigation
  作者：Dai-ichiro Kato、Satoshi Mitsuda、Hiromichi Ohta

  DOI：10.1021/jo034253x

  日期：2003.9.1

  A new enzymatic method for the preparation of optically active alpha-substituted carboxylic acids is reported. This technique is called deracemization reaction, which provides us with a route to obtain the enantiomerically pure compounds, theoretically in 100% yield starting from the racemic mixture. This means that the synthesis of a racemate is almost equal to the synthesis of the optically active

  报道了一种用于制备旋光的α-取代的羧酸的新的酶促方法。这项技术称为脱硝反应，它为我们提供了从外消旋混合物开始，理论上以100％的收率获得对映体纯化合物的途径。这意味着外消旋体的合成几乎与旋光化合物的合成相同，并且该概念与不对称合成中通常被接受的概念完全不同。使用不断增长的诺卡氏夜蛾诺卡氏菌JCM3208的细胞系统，可以使2-芳基-和2-芳基氧基丙酸的外消旋物顺利脱硫，并以高化学收率（> 50％）回收富含（R）-形式的产物。此外，使用旋光性起始化合物和氘代衍生物以及抑制剂，
• Inhibitors of glycogen synthase kinase 3
  申请人：——

  公开号：US20020156087A1

  公开（公告）日：2002-10-24

  New pyrimidine or pyridine based compounds, compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) in vitro and of treatment of GSK3 mediated disorders in vivo are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder, immunodeficiency or cancer.

  提供新的基于嘧啶或吡啶的化合物、组合物以及抑制糖原合酶激酶（GSK3）活性的方法和治疗GSK3介导的体内疾病的方法。发明的方法、化合物和组合物可以单独使用，或者与其他药理活性物质结合使用，在治疗由GSK3活性介导的疾病中，如糖尿病、阿尔茨海默病和其他神经退行性疾病、肥胖、动脉粥样硬化性心血管疾病、原发性高血压、多囊卵巢综合征、X综合征、缺血、创伤性脑损伤、双相情感障碍、免疫缺陷或癌症。
• [EN] INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3<br/>[FR] INHIBITEURS DE GLYCOGENE SYNTHASE KINASE 3
  申请人：CHIRON CORPORATION

  公开号：WO1999065897A1

  公开（公告）日：1999-12-23

  (EN) New pyrimidine or pyridine based compounds, having the structure (I), compositions and methods of inhibiting the activity of glycogen synthase kinase (GSK3) $i(in vitro) and of treatment of GSK3 mediated disorders $i(in vivo) are provided. The methods, compounds and compositions of the invention may be employed alone, or in combination with other pharmacologically active agents in the treatment of disorders mediated by GSK3 activity, such as in the treatment of diabetes, Alzheimer's disease and other neurodegenerative disorders, obesity, atherosclerotic cardiovascular disease, essential hypertension, polycystic ovary syndrome, syndrome X, ischemia, traumatic brain injury, bipolar disorder immunodeficiency or cancer.(FR) L'invention concerne de nouveaux composés à base de pyrimidine ou de pyridine de la structure (I), des compositions et méthodes d'inhibition de l'activité de glycogène synthase kinase (GSK3) $i(in vitro) et de traitement de troubles induits par GSK3 $i(in vivo). Les méthodes, composés et compositions de la présente invention peuvent s'utiliser seuls ou en combinaison avec d'autres agents actifs du point de vue pharmacologique pour le traitement de troubles induits par l'activité de GSK3, tels que le diabète, la maladie d'Alzheimer et d'autres troubles neurodégénératifs, l'obésité, une maladie cardiovasculaire athéroscléreuse, l'hypertension artérielle essentielle, le syndrome des ovaires polkykystiques, le syndrome X, l'ischémie, le traumatisme cérébral, un trouble bipolaire, l'immunodéficience ou le cancer.

  新的以嘧啶或吡啶为基础的化合物，具有结构（I），提供了抑制糖原合成酶激酶（GSK3）$i（in vitro）活性和治疗GSK3介导的疾病$i（in vivo）的组合物和方法。本发明的方法、化合物和组合物可以单独使用，也可以与其他药理活性剂联合使用，用于治疗由GSK3活性介导的疾病，如糖尿病、阿尔茨海默病和其他神经退行性疾病、肥胖症、动脉粥样硬化心血管疾病、原发性高血压、多囊卵巢综合症、X综合症、缺血、创伤性脑损伤、双相情感障碍、免疫缺陷或癌症。
• π-Allyl palladium ring closure strategy for the synthesis of a 1β-methylcarbapenem intermediate
  作者：Sylvain Roland、Jean Olivier Durand、Monique Savignac、Jean Pierre Genêt、Frédéric Jung

  DOI：10.1016/0040-4039(95)00448-l

  日期：1995.4

  A new ring closure by pi-allyl palladium methodology is utilized in the synthesis of a 1-beta-methyl carbapenem intermediate from 2-acetoxy azetidinone in six steps (40% yield).
• Microbial deracemization of α-substituted carboxylic acids: control of the reaction path
  作者：Dai-ichiro Kato、Kenji Miyamoto、Hiromichi Ohta

  DOI：10.1016/j.tetasy.2004.06.049

  日期：2004.9

  A novel approach to preparing optically active alpha-substituted carboxylic acids using the whole cells of Nocardia diaphanozonaria JCM 3208 is described. When 2-phenylthiopropanoic acid and 2-methyl-3-phenylpropanoic acid were subjected to the reaction under aerobic conditions, the oxidation reaction proceeded preferentially rather than deracemization of these substrates. Herein, we report the design of reaction conditions to increase the deracemization activity in preference to oxidation reactions. In addition, we have successfully detected a metabolic intermediate in the reaction mixture of 2-methyl-3-plienylpropanoic acid, which indicates that the deracemization is a competitive reaction against the beta-oxidation pathway of fatty acid metabolism. (C) 2004 Elsevier Ltd. All rights reserved.